Schlosspark-Klinik

Hospital


Location: Berlin, Germany (DE) DE

ISNI: 0000000403894732

ROR: https://ror.org/03kbxr932

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs (2017) Figueiredo CP, Bang H, Cobra JF, Englbrecht M, Hueber A, Haschka J, Manger B, et al. Journal article EFFECTS OF DMARD TAPERING ON TREATMENT COSTS IN RHEUMATOID ARTHRITIS PATIENTS-AN ANALYSIS FROM THE PROSPECTIVE RANDOMIZED CONTROLLED RETROSTUDY (2016) Hagen M, Figueiredo C, Cobra JF, Reiser M, Haschka J, Englbrecht M, Hueber A, et al. Conference contribution Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment (2016) Rech J, Hueber A, Finzel S, Englbrecht M, Haschka J, Manger B, Kleyer A, et al. Journal article Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study (2016) Haschka J, Englbrecht M, Hueber A, Manger B, Kleyer A, Reiser M, Finzel S, et al. Journal article Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh) (2016) Kiltz U, Alten R, Fleck M, Krueger K, Manger B, Mueller-Ladner U, Nusslein H, et al. Journal article RETRO - STUDY OF REDUCTION OF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ONGOING REMISSION (2015) Haschka J, Englbrecht M, Hueber A, Manger B, Kleyer A, Reiser M, Finzel S, et al. Conference contribution